.jpg)
.png)
All
The Practice Tools and Clinical Care Committee created new patient tear sheets. The three latest tear sheets are on coronary artery calcium testing, cardiovascular risk calculation, and high blood triglycerides. To access all tear sheets, click here.
Welcome to this edition of LipidSpin the MWLA has put together in partnership with our colleagues of the PLA focusing on atherogenic particles. LipidSpin is a fantastic opportunity to showcase collaborative work in the field of lipidology and this edition shows that lipidology is imperative to so... more
I am honored to be leading the Midwest Lipid Association this year. I started working for Ohio State 25 years ago and had a variety of teaching duties with medical students, residents, and fellows with a primary emphasis on psychiatry and cardiovascular prevention. I was asked to start a Lipid... more
It has been an honor to serve as the President of the National Lipid Association (NLA) for the 2018-19 organizational year, and I look forward to the rest of my term through the 2019 Scientific Sessions.
A Report of the American College of Cardiology Foundation/American Heart Association/ American College of Physicians Task Force on Competence and Training (Writing Committee to Develop a Competence and Training Statement on Prevention of Cardiovascular Disease) Developed in Collaboration With the... more
Related Organizations Explore different activities of our related organizations. The American Board of Clinical Lipidology The American Board of Clinical Lipidology (ABCL) is an independent physician-certifying organization... more
To my fellow National Lipid Association members, I am happy to welcome you to the first LipidSpin edition of 2021. Management of Residual Risk remains a pertinent topic in the field of Clinical Lipidology, and I feel our colleagues within the Pacific and Midwest chapters have done and excellent job... more
What is Lp(a) and Why Is It Important? In recent years, lipoprotein(a) [Lp(a)] has been recognized as a prevalent risk factor for cardiovascular disease. It is estimated that ~20% of the global population have elevated Lp(a) levels (greater than 50 mg/dL or 100 nmol/L). Lp(a) risk for major... more
This issue sponsored by the National Lipid Association Featuring: "Can Coronary Artery Disease Be Prevented?"